GlassScriptPhysician profile
Juan Herrada
NPI 1215934674
$437.37
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.90 · 2021: $159 · 2022: $53.32 · 2024: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128 · Education: $27.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.80 |
| Education | $27.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $127.80 | 2024 | Entre Plus, Flexitouch Plus |
| Amgen INC. | $99.99 | 2021 | |
| Genentech USA, INC. | $69.90 | 2019 | |
| Seagen INC. | $31.56 | 2021 | |
| Pfizer INC. | $27.70 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $21.57 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $16.72 | 2022 | |
| Incyte Corporation | $15.18 | 2021 | |
| Stemline Therapeutics INC. | $15.03 | 2022 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Herrada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.